NCT01999218
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
Not specified
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
8,008 public trials
712 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT03095651
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +8 more
- Locations
-
- ProSciento Inc. ( Site 0001) Chula Vista, California, United States
NCT01607294
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +8 more
- Locations
-
- Miramar, Florida, United States
NCT02375932
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
Not specified
NCT02589639
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Nakayama Clinic Aichi, Japan
- Kashiwa City Hospital Chiba, Kashiwa, Japan
- Kunisaki Makoto Clinic Fukuoka, Japan
- Saiseikai Fukuoka General Hospital Fukuoka, Fukuoka, Japan
Completed
Diabetes and Gastric By- Pass
NCT01153516
- Conditions
- Body Weight, Body Weight Changes, Diabetes Mellitus, +13 more
- Locations
-
- Clinical and Translational Research Center Dallas, Texas, United States
NCT02471404
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
- Research Site Hodonín, Czechia
- Research Site Hradec Králové, Czechia
- Research Site Jílové u Prahy, Czechia
- Research Site Ostrava - Belsky Les, Czechia
NCT01654341
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Hospital Universitario de Getafe Madrid, Getafe, Spain
NCT01513590
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Algiers, Algeria
- Novo Nordisk Investigational Site Oran, Algeria
- Novo Nordisk Investigational Site Sétif, Algeria
- Novo Nordisk Investigational Site Haskovo, Bulgaria
NCT03887403
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
Not specified